Inhibition of O-GlcNAc Transferase Renders Prostate Cancer Cells Dependent on CDK9
Harri M. Itkonen(Boston Biomedical Research Institute), Suzanne Walker(Boston Biomedical Research Institute)
Cited by 52
Related Papers
High OGT activity is essential for MYC-driven proliferation of prostate cancer cells
|Theranostics|2019|91
Multi-strain Tn-Seq reveals common daptomycin resistance determinants in Staphylococcus aureus
|PLoS Pathogens|2019|90
N-Linked Glycosylation Supports Cross-Talk between Receptor Tyrosine Kinases and Androgen Receptor
|PLoS ONE|2013|53
O-GlcNAc Transferase Inhibition Differentially Affects Breast Cancer Subtypes
|Scientific Reports|2019|36
Inhibition of CDK9 activity compromises global splicing in prostate cancer cells
|RNA Biology|2021|21